Literature DB >> 9712147

Human hematopoietic cell specific nuclear protein MNDA interacts with the multifunctional transcription factor YY1 and stimulates YY1 DNA binding.

J Xie1, J A Briggs, R C Briggs.   

Abstract

The human myeloid nuclear differentiation antigen, MNDA, is expressed only in myelomonocytic and a subset of B lymphoid hematopoietic cells. MNDA is uniformly distributed throughout the interphase cell nucleus and associates with chromatin, but does not bind specific DNA sequences. We recently demonstrated that MNDA binds nucleolin and nucleophosmin/NPM/B23 and both of these nuclear proteins bind the ubiquitous zinc finger transcription factor YY1. Investigations of the possible effect of MNDA on the interaction between YY1 and NPM, showed that MNDA bound YY1 directly under both in vitro and in vivo conditions. The MNDA-YY1 interaction enhanced the affinity of YY1 for its target DNA and decreased its rate of dissociation. The N-terminal half (200 amino acids) of MNDA was sufficient for maximum enhancement of YY1 DNA binding and a portion of this sequence was responsible for binding YY1. MNDA participated in a ternary complex with YY1 and the YY1 target DNA element. The results show that MNDA affects the ability of YY1 to bind its target DNA sequnce and that MNDA participates in a ternary complex possibly acting as a cofactor to impart lineage specific features to YY1 function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712147

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

Review 1.  Transcription and growth regulatory functions of the HIN-200 family of proteins.

Authors:  R W Johnstone; J A Trapani
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  The interferon-inducible nucleolar p204 protein binds the ribosomal RNA-specific UBF1 transcription factor and inhibits ribosomal RNA transcription.

Authors:  C J Liu; H Wang; P Lengyel
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

Review 3.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

Review 4.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

5.  Nucleolin is a histone chaperone with FACT-like activity and assists remodeling of nucleosomes.

Authors:  Dimitar Angelov; Vladimir A Bondarenko; Sébastien Almagro; Hervé Menoni; Fabien Mongélard; Fabienne Hans; Flore Mietton; Vasily M Studitsky; Ali Hamiche; Stefan Dimitrov; Philippe Bouvet
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

6.  Nucleolin is required for RNA polymerase I transcription in vivo.

Authors:  Brenden Rickards; S J Flint; Michael D Cole; Gary LeRoy
Journal:  Mol Cell Biol       Date:  2006-11-27       Impact factor: 4.272

7.  Sequence and chromatin determinants of cell-type-specific transcription factor binding.

Authors:  Aaron Arvey; Phaedra Agius; William Stafford Noble; Christina Leslie
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

Review 8.  Death domain fold proteins in immune signaling and transcriptional regulation.

Authors:  Yu-San Huoh; Sun Hur
Journal:  FEBS J       Date:  2021-05-13       Impact factor: 5.622

9.  Investigating the genetic architecture of disease resilience in pigs by genome-wide association studies of complete blood count traits collected from a natural disease challenge model.

Authors:  Xuechun Bai; Tianfu Yang; Austin M Putz; Zhiquan Wang; Changxi Li; Frédéric Fortin; John C S Harding; Michael K Dyck; Jack C M Dekkers; Catherine J Field; Graham S Plastow
Journal:  BMC Genomics       Date:  2021-07-13       Impact factor: 3.969

10.  The role of master regulators in the metabolic/transcriptional coupling in breast carcinomas.

Authors:  Karol Baca-López; Miguel Mayorga; Alfredo Hidalgo-Miranda; Nora Gutiérrez-Nájera; Enrique Hernández-Lemus
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.